8-K: KindlyMD Completes Nakamoto Merger, Boosts Bitcoin Treasury

Sentiment:

Merger and Financing Update


KindlyMD, Inc. has completed its merger with Nakamoto Holdings Inc., establishing a Bitcoin-native treasury vehicle, raising $540 million in PIPE financing, and securing a $200 million convertible note to fund Bitcoin acquisitions.

Capital raiseCompleted a Private Placement in Public Equity (PIPE) financing, generating approximately $540.0 million in gross proceeds.Issued an aggregate of 322,979,583 shares of Company Common Stock at $1.12 per share and 5,682,586 shares at $5.00 per share in the PIPE financing.Issued 133,800,773 pre-funded warrants to purchase shares of Common Stock in the PIPE financing.Closed a senior secured convertible note offering in an aggregate principal amount of $200.0 million to YA II PN, Ltd.The net proceeds from both the PIPE Financings and the Convertible Note offering are intended to be used primarily to purchase Bitcoin and for working capital and general corporate purposes.

Summary

  • Kindly MD, Inc. completed its merger with Nakamoto Holdings Inc. on August 14, 2025, with Nakamoto becoming a wholly-owned subsidiary and the combined entity retaining the KindlyMD name, trading as NAKA on Nasdaq.
  • The company closed a Private Placement in Public Equity (PIPE) financing, generating approximately $540 million in gross proceeds, and issued a $200 million senior secured convertible debenture to YA II PN, Ltd. on August 15, 2025.
  • The proceeds from these financings are primarily intended for purchasing Bitcoin and for general corporate purposes, with a stated mission to acquire one million Bitcoin for the Nakamoto treasury.
  • The convertible debenture bears 0% interest for the first two years, 6% for the third year, and matures on August 14, 2028, with an initial conversion price of $2.80 per common share, subject to a downward reset to 130% of VWAP (minimum $2.00).
  • The debenture is secured by Bitcoin collateral valued at no less than $400 million within 10 business days of funding, and must maintain a value of at least 2x the principal amount.
  • Kindly MD's tradeable warrants were delisted from Nasdaq and will now be quoted on the OTC Pink Market due to not meeting the 100 round lot holder requirement, though the common stock listing on the Nasdaq Global Market remains unaffected and was uplisted.
  • The company appointed a new leadership team, including David Bailey as CEO and Chairman, Amanda Fabiano as COO, Tyler Evans as CIO, and Andrew Creighton as CCO, while Tim Pickett transitioned from CEO to Chief Medical Officer and remains a director.
  • The Board of Directors was significantly reconstituted with the appointment of six new independent directors: Charles Blackburn, Perianne Boring, Eric Weiss, Greg Xethalis, and Mark Yusko, alongside David Bailey and Tim Pickett.
  • Corporate governance documents were amended, including an increase in authorized shares from 110 million to 10.01 billion, a requirement for shareholder action only by meeting, and the adoption of new Code of Ethics, Clawback, and Insider Trading policies.

Sentiment

Score: 7

Explanation: The filing details the successful completion of a transformative merger, significant capital raises, and a clear strategic pivot towards Bitcoin treasury management, led by a new, experienced management team. The uplisting to Nasdaq Global Market is also a positive. However, the inherent volatility and regulatory risks associated with Bitcoin, coupled with the delisting of warrants and potential dilution, introduce considerable uncertainty and risk, preventing a higher score. The company's ambitious Bitcoin acquisition target and the new leadership's expertise in the crypto space suggest strong growth potential, but also high risk.

Positives

  • Successfully completed the strategic merger with Nakamoto Holdings Inc., creating a diversified entity focused on healthcare and Bitcoin treasury management.
  • Secured substantial capital through a $540 million PIPE financing and a $200 million secured convertible note, providing significant funds for Bitcoin acquisitions and general corporate purposes.
  • Uplisted the common stock to the Nasdaq Global Market, which is expected to enhance visibility, increase liquidity, and expand investor awareness.
  • Appointed a new, experienced leadership team and a board of directors with deep expertise in finance, digital assets, and corporate governance, including David Bailey as CEO and Chairman.
  • Established a clear strategic vision to build a premier institutional-grade Bitcoin treasury vehicle with a mission to acquire one million Bitcoin and facilitate institutional adoption.
  • Achieved Well-Known Seasoned Issuer (WKSI) status, allowing for streamlined and flexible capital market access.
  • Implemented robust corporate governance updates, including a new Code of Ethics, Clawback Policy, and Insider Trading Policy, aligning with regulatory best practices.

Negatives

  • Tradeable warrants were delisted from Nasdaq due to non-compliance with listing rules (fewer than 100 round lot holders), potentially impacting liquidity and investor interest in the warrants.
  • The company's strategy involves significant concentration of assets in highly volatile Bitcoin, exposing it to substantial price fluctuation risks.
  • The Bitcoin treasury strategy is new and untested over an extended period or under different market conditions, introducing uncertainty regarding its long-term success.
  • Reliance on third-party exchanges and custodians for Bitcoin transactions and custody introduces counterparty risks, including potential loss in insolvency proceedings or security breaches.
  • The potential for future acquisitions of BTC Inc. and UTXO, if they occur, could lead to substantial dilution for existing shareholders.
  • The new CEO, David Bailey, will not devote his full time and attention to the company, as he continues to lead BTC, Inc., which could pose management focus risks.
  • The company has incurred significant indebtedness ($200 million convertible note) and may incur more, which could impair future capital raising or debt servicing ability.
  • The merger and related transactions are expected to incur significant non-recurring costs, which may exceed anticipations and adversely affect financial condition.
  • The company's stock price may be adversely affected by the availability of spot Bitcoin ETPs, as investors may choose these alternatives for Bitcoin exposure.

Risks

  • Bitcoin is a highly volatile asset, and fluctuations in its price are likely to significantly influence financial results and the market price of listed securities.
  • The vast majority of assets will be concentrated in Bitcoin holdings, limiting risk mitigation through diversification.
  • Ability to achieve Bitcoin strategy objectives depends on obtaining equity and debt financing, which may not be available on favorable terms or at all.
  • The Bitcoin strategy has not been tested over an extended period or under different market conditions.
  • Subject to counterparty risks, particularly relating to exchanges and custodians, including potential loss of custodially-held Bitcoin in insolvency proceedings.
  • The broader digital assets industry is subject to counterparty risks, which could adversely impact Bitcoin adoption, price, and use.
  • Bitcoin and other digital assets are novel and subject to significant legal, commercial, regulatory, and technical uncertainty, including potential adverse interpretations or new laws.
  • The emergence or growth of other digital assets, including those with significant private or public sector backing (e.g., stablecoins, CBDCs), could negatively impact Bitcoin's price.
  • Bitcoin holdings are less liquid than cash and cash equivalents and may not serve as a source of liquidity during market instability.
  • Risk of security breaches or cyberattacks leading to loss of Bitcoin, or loss/destruction of private keys.
  • Regulatory change classifying Bitcoin as a security could lead to the company's classification as an investment company under the Investment Company Act of 1940, subjecting it to significant additional regulatory controls.
  • Risk of non-performance by counterparties in Bitcoin-related transactions.
  • Future business strategy may include acquisitions and investments in companies with Bitcoin strategies, posing integration risks and potential dilution.
  • Incurred and may incur significant indebtedness, which could impair ability to raise further capital or service debt.
  • Completion of the merger may trigger change in control provisions in existing agreements, leading to potential termination or renegotiation on less favorable terms.
  • Significant transaction costs associated with the merger and integration may exceed anticipations.
  • Failure to successfully combine businesses or realize anticipated benefits and synergies from the merger.
  • No guarantee of future acquisition of BTC Inc. or UTXO, and if acquired, could result in substantial shareholder dilution.
  • Merger may create disruption and uncertainty for employees, potentially leading to loss of key personnel.
  • Litigation relating to the merger could result in substantial costs and adversely affect business.
  • Shareholders will not be entitled to appraisal rights in the merger under Utah law.
  • The trading price and volume of the company's stock may be volatile post-merger due to different influencing factors and market perception.
  • Directors and executive officers' social media activity may pose risks to reputation, create regulatory/disclosure concerns, and impact stock price.
  • High dependence on CEO David Bailey, who does not devote full time to the company and has other affiliations, potentially leading to conflicts of interest or reduced focus.
  • No key person life insurance policies for critical personnel.

Future Outlook

The company aims to build a premier institutional-grade Bitcoin treasury vehicle, with a long-term mission to acquire one million Bitcoin and integrate Bitcoin into global capital markets. It plans to develop a full suite of products and services to facilitate institutional adoption of Bitcoin and establish itself as a leading public market platform for Bitcoin treasury management.

Management Comments

  • "Our vision is for the world's capital markets to operate on a Bitcoin standard. Today's merger represents the beginning of that journey for our company." David Bailey, CEO
  • "Since I started my journey in Bitcoin 13 years ago, I've always believed Bitcoin would become the most valuable asset in human history, held by every person, company, and government. The securitization of Bitcoin has shown us how institutions will adopt it. We intend to drive that forward." David Bailey, CEO
  • "We are thrilled to officially close our merger with Nakamoto. We've built KindlyMD on operational and innovative excellence, and we are now extending that same principle to our capital strategy." Tim Pickett, Chief Medical Officer
  • "Bitcoin gives us the ability to preserve value with the same integrity we apply to delivering care. We look forward to advancing our mission of acquiring Bitcoin at scale and driving sustained value for our shareholders." Tim Pickett, Chief Medical Officer
  • "The strong support we continue to receive from investors is validation of our pioneering Bitcoin treasury strategy. We are excited to leverage our enhanced balance sheet and differentiated go-to-market strategy to acquire as much Bitcoin as possible." David Bailey, CEO

Industry Context

This announcement signifies a notable shift for KindlyMD, a healthcare company, into the digital asset space through its merger with Nakamoto Holdings. This move aligns with a broader trend of companies exploring Bitcoin as a treasury reserve asset, following pioneers like MicroStrategy. The company aims to capitalize on the growing institutional interest in Bitcoin and digital assets, positioning itself as a key player in integrating Bitcoin into traditional capital markets. The strategic focus on acquiring a significant amount of Bitcoin (1 million BTC target) and developing related financial services places KindlyMD directly in competition with, or in a complementary role to, existing Bitcoin-focused entities and investment vehicles, including newly approved spot Bitcoin ETPs.

Comparison to Industry Standards

  • The company's strategy to hold Bitcoin as a primary treasury reserve asset is comparable to MicroStrategy, which has aggressively accumulated Bitcoin, holding over 214,400 BTC as of April 2024. KindlyMD's stated mission to acquire one million Bitcoin is an ambitious target, significantly larger than MicroStrategy's current holdings, positioning it as a potential leader in corporate Bitcoin treasuries if achieved.
  • The capital raise of $740 million ($540M PIPE + $200M convertible note) is substantial for a company of KindlyMD's prior size, indicating strong investor confidence in its new Bitcoin-centric strategy, similar to the large capital raises seen by other digital asset companies or Bitcoin miners.
  • The uplisting to Nasdaq Global Market is a positive step, aligning with the listing standards of established technology and financial companies, and is a common goal for companies seeking enhanced liquidity and institutional investor access.
  • The appointment of a board and management team with extensive experience in Bitcoin and digital assets, including figures like Perianne Boring (Digital Chamber) and Mark Yusko (Morgan Creek Digital Assets), brings industry-specific expertise comparable to specialized digital asset investment firms or blockchain technology companies.
  • The convertible debenture's 0% interest for the first two years is a favorable term, reflecting the potential for equity upside and the current market's appetite for Bitcoin-linked investments, similar to terms seen in growth-stage tech or crypto companies.
  • The requirement to maintain Bitcoin collateral at 2x the principal amount of the debt financing is a conservative leverage ratio compared to some highly leveraged Bitcoin mining operations, but still exposes the company to significant Bitcoin price volatility.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerTim PickettDavid BaileyAugust 14, 2025Merger-related strategic appointment.
Chief Medical OfficerN/ATim PickettAugust 14, 2025Transition from CEO role post-merger.
Chief Operating OfficerAdam CoxAmanda FabianoAugust 14, 2025Merger-related strategic appointment.
Chief Investment OfficerN/ATyler EvansAugust 14, 2025Merger-related strategic appointment.
Chief Commercial OfficerN/AAndrew CreightonAugust 14, 2025Merger-related strategic appointment.
DirectorAdam CoxN/AAugust 14, 2025Resignation from Board.
DirectorGary SeelhorstN/AAugust 14, 2025Resignation from Board.
DirectorChristian RobinsonN/AAugust 14, 2025Resignation from Board.
DirectorAmy PowellN/AAugust 14, 2025Resignation from Board.
DirectorN/ADavid BaileyAugust 14, 2025Appointment to Board post-merger.
Director (Independent)N/ACharles (Chad) BlackburnAugust 14, 2025Appointment to Board post-merger.
Director (Independent)N/APerianne BoringAugust 14, 2025Appointment to Board post-merger.
Director (Independent)N/AEric WeissAugust 14, 2025Appointment to Board post-merger.
Director (Independent)N/AGreg XethalisAugust 14, 2025Appointment to Board post-merger.
Director (Independent)N/AMark YuskoAugust 14, 2025Appointment to Board post-merger.
Chief Financial OfficerJared BarreraJared Barrera (interim)August 14, 2025Continues in role until new CFO is retained, anticipated October 1, 2025.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorized Shares IncreaseIncreased authorized shares from 110,000,000 to 10,010,000,000 (10,000,000,000 common, 10,000,000 preferred).August 11, 2025Provides significant flexibility for future equity issuances, including for acquisitions and capital raises, but also enables substantial dilution.
Shareholder Action RequirementAny action required or permitted by shareholders may only be effected at a duly called annual or special meeting, prohibiting action by written consent.August 11, 2025Increases formality and potentially time required for shareholder actions, centralizing decision-making to formal meetings.
Exclusive Forum ProvisionAll actions should be brought exclusively in the United States District Court for the District of Utah and Utah State court in Salt Lake County, Utah.August 11, 2025Limits the venues for legal disputes, potentially reducing litigation costs and forum shopping, but may inconvenience parties outside Utah.
Director Term StructureRemoved provisions prohibiting classes of directors with staggered terms and established three-year terms for directors.May 18, 2025May impact board stability and shareholder influence over board composition over time.
Advance Notice RequirementsEstablished advance notice requirements for business brought before annual shareholder meetings, including director nominees.May 18, 2025Provides management with more time to review and respond to shareholder proposals and nominations.
Code of Ethics and Business ConductAmended and restated to broaden applicability to consultants and contractors, increase managerial responsibility, provide more examples for conflicts of interest, and detail protection of company assets, corporate opportunities, confidentiality, and fair dealing.August 14, 2025Strengthens ethical guidelines and compliance framework across a wider range of personnel, aiming to reduce misconduct and enhance corporate integrity.
Clawback PolicyAmended and restated to comply with Section 10D of the Exchange Act, expanding covered executives, specifying incentive compensation subject to recovery, detailing calculation and recovery of excess compensation, and prohibiting indemnification for lost compensation.August 14, 2025Enhances accountability for executive compensation tied to financial reporting, aligning with regulatory standards and potentially deterring financial misstatements.
Insider Trading PolicyAmended and restated to reflect current best practices and new SEC requirements, expanding scope to consultants, contractors, and family members, updating the Compliance Officer role, clarifying blackout periods, and detailing Rule 10b5-1 plans.August 14, 2025Strengthens controls against insider trading, reduces legal and reputational risks, and ensures compliance with evolving securities regulations.
2025 Equity Incentive PlanApproved by Board and stockholders, reserving 37,611,971 shares for awards.August 14, 2025Provides a framework for attracting and retaining talent through equity compensation, but also introduces potential for future dilution.

Legal Proceedings

  • No new legal proceedings were explicitly mentioned as pending or threatened against the company, beyond the general risk factor that litigation relating to the merger could occur.

Related Party Transactions

  • David Bailey's mother participated in the PIPE Financings.
  • David Bailey's family members, Calli Bailey and Emily Bailey, are affiliated with BTC Inc.
  • Consulting agreement with BTC Consulting, LLC, an entity controlled by David Bailey, for his CEO services.
  • Tyler Evans is a party to a marketing agreement between BTC Inc. and Nakamoto Holdings Inc., under which BTC Inc. is owed a monthly retainer of $80,000.
  • Consulting agreement with Second Gate Advisory LLC, an entity controlled by Amanda Fabiano, for her COO services, with a signing bonus contingent on transitioning revenue from Second Gate Advisory LLC to the Company.
  • Mark Yusko, a new independent director, participated in the PIPE Financings, purchasing 2,100,000 shares of Common Stock.

Stakeholder Impact

  • Shareholders: Significant dilution from merger shares, PIPE shares, pre-funded warrants, and convertible debentures. Potential for future dilution from equity incentive plan and potential acquisitions. Exposure to high volatility of Bitcoin price. Potential for enhanced value if Bitcoin strategy is successful.
  • Employees: Changes in management roles and compensation structures. Uncertainty regarding roles post-merger. New equity incentive plan provides opportunities.
  • Customers (KindlyMD healthcare): The merger and strategic shift to Bitcoin treasury management may or may not directly impact healthcare services, but the company's focus and resources will be diversified.
  • Suppliers/Creditors: The company's increased capital base and strategic direction may affect relationships, but also introduces new risks related to Bitcoin holdings and indebtedness.
  • Regulatory Authorities: Increased scrutiny due to the company's significant Bitcoin holdings and digital asset strategy, requiring strict compliance with evolving regulations.

Next Steps

  • File registration statements for the resale of common stock issued in the merger, PIPE financing, and convertible debenture, and for the fee shares, within 30 calendar days of closing.
  • Cause the registration statements to be declared effective as soon as practicable, but no later than 60 calendar days (or 90 days if SEC reviews) following the closing.
  • Deposit at least $400,000,000 of Bitcoin into the Designated Digital Assets Account within 10 business days following the funding of the Debt Financing.
  • Retain a new Chief Financial Officer, with Jared Barrera's resignation anticipated around October 1, 2025.
  • Enter into standard Indemnification Agreements with the newly appointed directors.
  • Consider implementing a commission compensation program for the Chief Commercial Officer within 60 business days.
  • Continually examine the risks and rewards of the Bitcoin acquisition and holding strategy.
  • Potentially expand operations beyond the legacy medical business and Bitcoin treasury strategy to include other income streams and generate funds using Bitcoin holdings.
  • Potentially pursue future acquisitions of BTC Inc. and/or UTXO, LLC.

Key Dates

DateDescription
2023-09-01Effective date of Executive Employment Agreement with Tim Pickett and Jared Barrera.
2024-03-28Filing date of Company's Annual Report on Form 10-K for the year ended December 31, 2024.
2024-05-23SEC approved rule changes permitting listing and trading of spot ETPs that invest in ether.
2024-07-23Approved spot ETPs for ether commenced trading directly to the public.
2024-08-14Effective date of Consulting Agreement with Second Gate Advisory LLC (Amanda Fabiano).
2024-10-14Date of Addendum to Employment Agreement with Jared Barrera.
2025-01-01Greg Xethalis became a director of the Blockchain Association, Inc.
2025-01-10SEC approved listing and trading of spot bitcoin ETPs.
2025-01-11Approved spot ETPs for bitcoin commenced trading directly to the public.
2025-01-20SEC announced the formation of a Crypto Task Force.
2025-03-01Andrew Creighton became Secretary of Nakamoto Holdings Inc.
2025-03-01Charles Blackburn became an advisor at Monarrch.
2025-04-01Andrew Creighton became Interim Chief Commercial Officer/Corporate Development at BTC Inc.
2025-04-01Tyler Evans became a board director at Metaplanet Inc.
2025-05-01Perianne Boring became Founder and President of The Digital Future Foundation 501(c)(4).
2025-05-01Perianne Boring became Chair of the board of The Digital Chamber 501(c)(6) Trade Association.
2025-05-11Date of Secured Convertible Debenture Purchase Agreement between Company and Buyers.
2025-05-12Date of Merger Agreement between Kindly, Kindly Holdco Corp, Nakamoto, and Wade Rivers, LLC.
2025-05-12Date of Marketing Services Agreement between Nakamoto and BTC Inc.
2025-05-12Date of Secured Convertible Debenture Purchase Agreement between Kindly and YA II PN, Ltd.
2025-05-12Date of Initial Subscription Agreements for PIPE Financings.
2025-05-12Date of Addendum to Executive Employment Agreement with Tim Pickett.
2025-05-12Date of Addendum to Executive Employment Agreement with Jared Barrera.
2025-05-18Board approved 2025 Equity Incentive Plan and Second Amended and Restated Bylaws. Stockholders approved 2025 Equity Incentive Plan.
2025-05-20Previously reported date of Board and shareholder approval of Second and Amended and Restated Articles of Incorporation and Second Amended and Restated Bylaws.
2025-06-19Date of Additional Subscription Agreements for PIPE Financings.
2025-06-30End of quarter for Company's Quarterly Report on Form 10-Q filed on August 5, 2025.
2025-07-22Filing date of Company's Definitive Information Statement disclosing shareholder approval for the Merger.
2025-08-05Filing date of Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
2025-08-11Effective date of Second and Amended and Restated Articles of Incorporation with Utah Division of Corporations.
2025-08-11Date of earliest event reported in the 8-K filing.
2025-08-14Closing Date of merger between Kindly MD, Inc. and Nakamoto Holdings Inc.
2025-08-14Company received written notice from Nasdaq regarding Warrants delisting.
2025-08-14Completion of PIPE Financings.
2025-08-14Effective date of director resignations and appointments.
2025-08-14Tim Pickett and Adam Cox stepped down from CEO and COO roles, respectively.
2025-08-14David Bailey appointed CEO and Director.
2025-08-14Tyler Evans appointed Chief Investment Officer.
2025-08-14Andrew Creighton appointed Chief Commercial Officer.
2025-08-14Amanda Fabiano appointed Chief Operating Officer.
2025-08-14Board approved amended and restated Clawback Policy and Insider Trading Policy.
2025-08-14Company issued press release announcing merger closing.
2025-08-15Issuance Date of Secured Convertible Debenture.
2025-08-15Warrants removed from listing and registration on Nasdaq Stock Market and quoted on OTC Pink Market.
2025-08-15Company issued press releases announcing uplist to Nasdaq Global Market LLC and closing of Debt Financings.
2025-08-15Trading on Nasdaq Global Market commenced under NAKA ticker.
2025-08-25Deadline for depositing $400M Bitcoin collateral (10 Business Days after Aug 14, 2025).
2025-09-13Filing Deadline for initial Registration Statement for resale of Convertible Shares and Convert Fee Shares (30 calendar days after Aug 14, 2025).
2025-09-13Filing Deadline for registration statement for resale of PIPE Shares and Pre-Funded Warrants (30 calendar days after Aug 14, 2025).
2025-10-01Anticipated date for Jared Barrera's resignation as CFO.
2025-10-13Effectiveness Deadline for initial Registration Statement for resale of Convertible Shares and Convert Fee Shares (60 calendar days after Aug 14, 2025, assuming no SEC review).
2025-10-13Effectiveness Deadline for registration statement for resale of PIPE Shares and Pre-Funded Warrants (60 calendar days after Aug 14, 2025, assuming no SEC review).
2025-12-12Effectiveness Deadline for initial Registration Statement for resale of Convertible Shares and Convert Fee Shares (90 calendar days after Aug 14, 2025, if SEC reviews).
2025-12-12Effectiveness Deadline for registration statement for resale of PIPE Shares and Pre-Funded Warrants (90 calendar days after Aug 14, 2025, if SEC reviews).
2028-08-14Maturity Date of Secured Convertible Debenture.

Recommendation

hold

The company has undergone a significant and transformative merger, raising substantial capital and pivoting towards a Bitcoin treasury strategy with a new, experienced leadership team. This presents a high-risk, high-reward scenario. While the capital infusion and strategic focus on Bitcoin could lead to significant upside if Bitcoin's value appreciates and the strategy is successfully executed, the inherent volatility of Bitcoin, coupled with regulatory uncertainties, potential dilution, and integration risks, introduces considerable downside. The delisting of warrants and the CEO's part-time commitment also add to the risk profile. A 'hold' recommendation is appropriate for investors who are already exposed to the stock and are comfortable with the elevated risk profile, allowing them to observe the execution of the new strategy and the performance of Bitcoin. New investors should exercise extreme caution and conduct thorough due diligence before considering an investment, given the speculative nature of the new business model.

Keywords

Bitcoin treasury, digital assets, merger, convertible debenture, PIPE financing, Nasdaq uplisting, corporate governance, risk management, cryptocurrency, blockchain, KindlyMD, Nakamoto Holdings, YA II PN Ltd, Yorkville Advisors, David Bailey, institutional adoption

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.